ANZEMET is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Validus Pharmaceuticals Llc. The primary component is Dolasetron Mesylate.
Product ID | 30698-220_3b3a8574-591c-46b7-99cc-adca27a22c01 |
NDC | 30698-220 |
Product Type | Human Prescription Drug |
Proprietary Name | ANZEMET |
Generic Name | Dolasetron Mesylate |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 1997-09-11 |
Marketing Category | NDA / |
Application Number | NDA020623 |
Labeler Name | Validus Pharmaceuticals LLC |
Substance Name | DOLASETRON MESYLATE |
Active Ingredient Strength | 50 mg/1 |
Pharm Classes | Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 1997-09-11 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
30698-120 | ANZEMET | dolasetron mesylate |
30698-121 | ANZEMET | dolasetron mesylate |
30698-220 | ANZEMET | dolasetron mesylate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
![]() ANZEMET 74343289 1863035 Live/Registered |
U.S. PHARMACEUTICALS HOLDINGS II, LLC 1992-12-28 |